GHEC affiliate profile CF Boyle … 08-Nov-13
Name
Affiliations
Narrative
(brief; refer to
detailed
information on
projects and
publications
below)
Goals
Selected
projects and
plans
Collaborators
(selected)
5 key
publications
Teaching
Skills
Substantive
areas
Colin F. Boyle, MPP, MBA
GHS, Haas Center for Nonprofit and Public Leadership
Nearly twenty years of management consulting expertise advising companies,
nonprofits and governmental agencies on strategic and operational performance
improvement. Extensive experience in Global Health issues and conditions, including
malaria, HIV/AIDS, reproductive health, maternal and child health, nutrition, product
development and R&D, portfolio management, forecasting, and structuring market
interventions to increase uptake of novel interventions. Former clients and
collaborators include WHO, UNITAID, the Bill & Melinda Gates Foundation, the World
Bank, a range of biotech and pharmaceutical companies, and several product
development public-private partnerships.
 Bring the best of business strategy and management to the problems of global health
 Ensure GHS is focused on leveraging the full set of capabilities at UCSF and
collaborating institutions to address problems of health inequity
 Lancet Commission on Investing in Health – For “Global Health 2035”, led analysis of
Grand Convergence in Health for high-level Lancet Commission marking the 20th
anniversary of the 1993 World Development Report on Health. Paper forthcoming.
 UNITAID malaria market forecast – Led consortium of academic and NGO
forecasters in production of regular projections of demand and supply for the
artemisinin and ACT markets, in light of the test of the AMFm subsidy pilot. Involved
detailed modeling of demand based on funding flows and derivation of implications
for funders and policymakers.
 FIRST – Program manager for BMGF- and Carlos Slim Health Institute-funded
program to develop new tools for neglected tropical diseases, specifically Chagas,
dengue and onchocerciasis.
 Delivery strategies – Helped leading foundations (e.g., Gates) and PDPPPs develop
strategies for increasing the successful uptake of innovative new products in global
health. Efforts included development of “proof of deliverability” concepts, the
identification of barriers to uptake, recruitment of new capabilities and
organizational changes to increase focus on downstream interventions.
 Portfolio strategies – Conducted a range of portfolio strategies for drug developers,
foundations, and PPPs aimed at increasing their probability of successful innovation
and health impact.
 Economists & modelers: C Levin (UW), D Jamison (UW/UCSF), K Stenberg (WHO), H
Axelson (WHO), DCP3 network, A Woolsey and J Cohen (CHAI).
 Researchers: E Harris (UC-Berkeley), J McKerrow (UCSF), R Linnington (UCSC), M
Busch (BSRI), J Coloma (UC-B and Sustainable Sciences Institute), S Buluswar
(Lawrence Berkeley National Labs)
 Funders: BMGF, Unitaid.
 Lancet Commission report on “Global Health 2035” – due for publication on Dec 3.
MBA 292 A (Haas School of Business): Strategic Management of Nonprofits, mentoring
Established: Strategy, management, pricing, organizational design, operations, portfolio
modeling, project planning, forecasting, cost effectiveness modeling (One Health) for
intervention and diseases, organizational governance.
Desired: Interested in many other things.
Established: HIV, malaria, reproductive health, maternal and child health, nutrition,
neglected tropical diseases, strategy, operations, and forecasting.
Desired: Interested in many other things
Page 1 of 2
Page 2 of 2